Skip to main content

3 articles related to "Sglt Inhibitor"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 17 Mar 2020

Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats

in Clinical Diabetes

Qiuyue Lv
Liang Le
Jiamei Xiang
Baoping Jiang
Sibao Chen
Peigen Xiao

Frontiers in Endocrinology

doi 10.3389/fendo.2020.00111

6,996 views
21 citations

Original Research

Published on 20 Oct 2025

Comparative cardiovascular risks of canagliflozin and selective SGLT2 inhibitors in type 2 diabetes

in Cardiovascular and Smooth Muscle Pharmacology

Edy Kornelius
Shih-Chang Lo
Yi-Sun Yang
Yu-Hsun Wang
Chien-Ning Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1686851

1,903 views

Original Research

Published on 20 Jun 2022

Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis

in Coronary Artery Disease

Rui Hua
Ning Ding
Hanqing Guo
Yue Wu
Zuyi Yuan
Ting Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.918167

11,668 views
38 citations